Tag: CBT > DEA Cannabis Policy and Legalization: Page 6

Legislation and Regulation

Federal Court Dismisses Lawsuit Against DEA Over Medical Cannabis Research

The DEA announced in August that it would expedite the review of cultivation license applications that have been pending for three years, making the lawsuit “moot,” according to the judge.

October 30, 2019

Legislation and Regulation

Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access

This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.

October 25, 2019

Colorado

Colorado-Based MedPharm Has Big Plans for Cannabis Research

The DEA has notified the company that it has been chosen to advance in the licensing process to grow federally legal cannabis for research purposes.

September 4, 2019

Legislation and Regulation

DEA Announces Cannabis Research Expansion Plans, Washington Eyes Bill Allowing Growers to Deliver: Week in Review

The DEA has pledged to take steps to approve additional federal cultivation licenses from a pool of applications that have been pending for nearly three years.

August 31, 2019

Top Stories

DEA Announces Steps to Expand Medical Cannabis Research

In a response to a lawsuit filed in June, the agency has pledged to approve additional federal cultivation licenses from a pool of applications that have been pending for nearly three years.

August 27, 2019

Industry Headlines

Colorado's MedPharm Clears Significant DEA Hurdle for Federal Cannabis Research License

MedPharm has been selected by the DEA to move forward as one of the first applicants to be granted a license to grow federally legal cannabis.

August 27, 2019

Industry Headlines

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

The DEA has once again pledged to take action to better facilitate clinical cannabis research.

August 26, 2019

Top Stories

Federal Court Orders DEA to Explain Why It Has Ignored Cannabis Cultivation Applications

Dr. Sue Sisley and the Scottsdale Research Institute have sued the DEA and Justice Department, demanding answers after their 2016 application was ignored.

August 6, 2019

Legislation and Regulation

President Trump Signs 2018 Farm Bill, Legalizing Hemp

The president signed the legislation into law Dec. 20, accelerating the hemp industry’s growth.

December 20, 2018

California

Federal Investigators Seize Cannabis Plants on Nearly 200 Acres in California

The grow was described as "one of the biggest marijuana grows ever seen in the Central Valley."

November 6, 2018

Distribution

DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?

With the DEA signaling a willingness to join the FDA in approving certain cannabis-derived drugs for sale, the industry looks ahead to more tidal shifts.

September 28, 2018

Legislation and Regulation

DEA Wants More Marijuana Grown, Fewer Opioids Produced in 2019

In a new Federal Register filing set to be published soon, the anti-drug agency is moving to more than quintuple the amount of cannabis that can legally be grown in the U.S. for research purposes.

August 20, 2018